|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Long Beach |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Los Angeles |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Napa Valley |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Oakland |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Palm Springs |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Pasadena |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Ranch Santa Fe |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Riverside |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Sacramento |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - San Bernardino Valley |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - San Diego |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - San Fernando |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - San Francisco |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - San Jose |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Santa Barbara |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Santa Monica |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Santa Rosa |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA - Ventura |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CA- Fresno |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CAN - Ontario |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CT - Bridgeport |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CT - Connecticut |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CT - New Haven |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: CT - Stamford |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: DC - District of Columbia |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: DE - Delaware |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: DE - Wilmington |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: NC - Raleigh |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: NC - Wilmington |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
|
|
| At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As a Diabetes Primary Care Sales Representative in Wheaton/Chicago IL, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
AstraZeneca's strategy in CVMD is a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) areas into one integrated approach – cardiovascular and metabolic disease (CVMD). This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease is a well-known consequence of diabetes and CKD. Each of ours focus areas seek to further reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods.
|
| Company: Astrazeneca |
Location: NC -Asheville |
Position: Pharmaceutical Sales |
Posted: 5/14/2025 |
|
|
